BRD4 Inhibition as a Strategy to Prolong the Response to Standard of Care in Estrogen Receptor-Positive Breast Cancer.
Cancers (Basel)
; 15(16)2023 Aug 11.
Article
in En
| MEDLINE
| ID: mdl-37627092
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Cancers (Basel)
Year:
2023
Document type:
Article
Affiliation country:
United States
Country of publication:
Switzerland